TARSUS PHARMACEUTICALS INC (TARS) Stock Earnings & Estimates
USA - NASDAQ:TARS - US87650L1035 - Common Stock
74.81 USD
-0.83 (-1.1%)
74.81 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25.82M -54.73% | 17.447M -32.43% | 182.953M 948.62% | 438.1M 139.46% | 656.75M 49.91% | 865.17M 31.74% | 966.92M 11.76% | 1.143B 18.21% | 1.247B 9.10% | 1.433B 14.92% | 1.524B 6.35% | |
| EBITDA YoY % growth | -62.38M -426.41% | -142.281M -128.09% | -119.344M 16.12% | -44.595M 62.63% | 112.85M 353.06% | 226.69M 100.88% | 91.912M -59.45% | 92.381M 0.51% | 92.84M 0.50% | N/A | N/A | |
| EBIT YoY % growth | -62.71M -415.71% | -143.158M -128.29% | -120.569M 15.78% | -66.632M 44.74% | 82.436M 223.72% | 226.9M 175.24% | 381.54M 68.15% | 544.97M 42.83% | 642.04M 17.81% | 821.95M 28.02% | 903.28M 9.89% | |
| Operating Margin | -242.87% | -820.53% | -65.90% | -15.21% | 12.55% | 26.23% | 39.46% | 47.68% | 51.49% | 57.36% | 59.27% | |
| EPS YoY % growth | -2.55 -275.00% | -4.64 -81.96% | -3.10 33.19% | -1.60 48.35% | 1.32 182.25% | 3.15 138.85% | 4.75 50.94% | 6.89 45.01% | 8.21 19.26% | 8.61 4.84% | 9.49 10.19% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 76.59% | 0.03 105.31% | 0.41 185.00% | 0.41 236.00% | 0.83 688.19% | 0.78 2,180.23% | 1.12 175.00% | 1.32 222.50% | 1.66 101.23% |
| Revenue Q2Q % growth | 146.37M 120.41% | 151.57M 93.49% | 173.62M 69.12% | 178.91M 50.73% | 200.23M 36.80% | 200.34M 32.18% | 222.59M 28.21% | 238.32M 33.21% | 257.85M 28.78% |
| EBITDA Q2Q % growth | 2.155M 109.29% | 6.088M 123.58% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.544M 81.39% | 11.513M 143.81% | 27.516M 224.04% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.30 50.82% | -0.36 | 0.06 | 16.07% |
| Q2 2025 Q2Q % growth | -0.48 45.45% | -0.41 | -0.07 | -17.77% |
| Q1 2025 Q2Q % growth | -0.64 36.63% | -0.75 | 0.11 | 14.11% |
| Q4 2024 Q2Q % growth | -0.60 54.20% | -0.76 | 0.16 | 20.78% |
| Q3 2024 Q2Q % growth | -0.61 52.34% | -0.99 | 0.38 | 38.50% |
| Q2 2024 Q2Q % growth | -0.88 24.79% | -0.94 | 0.06 | 6.62% |
| Q1 2024 Q2Q % growth | -1.01 -14.77% | -1.23 | 0.22 | 17.81% |
| Q4 2023 Q2Q % growth | -1.31 -167.35% | -1.39 | 0.08 | 5.75% |
| Q3 2023 Q2Q % growth | -1.28 -52.38% | -1.39 | 0.11 | 8.10% |
| Q2 2023 Q2Q % growth | -1.17 -387.50% | -1.10 | -0.07 | -6.36% |
| Q1 2023 Q2Q % growth | -0.88 10.20% | -0.96 | 0.08 | 8.70% |
| Q4 2022 Q2Q % growth | -0.49 31.94% | -0.70 | 0.21 | 30.38% |
| Q3 2022 Q2Q % growth | -0.84 -10.53% | -0.99 | 0.15 | 15.35% |
| Q2 2022 Q2Q % growth | -0.24 -172.73% | -0.60 | 0.36 | 60.15% |
| Q1 2022 Q2Q % growth | -0.98 -308.51% | -0.94 | -0.04 | -4.68% |
| Q4 2021 Q2Q % growth | -0.72 -5.88% | -0.74 | 0.02 | 2.98% |
| Q3 2021 Q2Q % growth | -0.76 79.51% | -0.44 | -0.32 | -71.68% |
| Q2 2021 Q2Q % growth | 0.33 | -0.49 | 0.82 | 167.87% |
| Q1 2021 Q2Q % growth | 0.47 | -0.65 | 1.12 | 172.00% |
| Q4 2020 Q2Q % growth | -0.68 | -0.67 | -0.01 | -1.01% |
| Q3 2020 Q2Q % growth | -3.71 | -0.54 | -3.17 | -586.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 118.697M 146.68% | 117.53M | 1.167M | 0.99% |
| Q2 2025 Q2Q % growth | 102.66M 151.54% | 97.596M | 5.064M | 5.19% |
| Q1 2025 Q2Q % growth | 78.335M 183.68% | 73.917M | 4.418M | 5.98% |
| Q4 2024 Q2Q % growth | 66.408M 407.86% | 59.494M | 6.914M | 11.62% |
| Q3 2024 Q2Q % growth | 48.118M 2,471.78% | 44.306M | 3.812M | 8.60% |
| Q2 2024 Q2Q % growth | 40.813M | 32.297M | 8.516M | 26.37% |
| Q1 2024 Q2Q % growth | 27.614M 1,004.56% | 17.805M | 9.809M | 55.09% |
| Q4 2023 Q2Q % growth | 13.076M 30.76% | 5.778M | 7.298M | 126.31% |
| Q3 2023 Q2Q % growth | 1.871M | 407.796K | 1.463M | 358.81% |
| Q2 2023 Q2Q % growth | -100.00% | 1.795M | -1.795M | -100.00% |
| Q1 2023 Q2Q % growth | 2.5M 362.96% | 3.188M | -688K | -21.58% |
| Q4 2022 Q2Q % growth | 10M 2,841.18% | 10.2M | -200K | -1.96% |
| Q3 2022 Q2Q % growth | -100.00% | 2.975M | -2.975M | -100.00% |
| Q2 2022 Q2Q % growth | 15.28M -30.61% | 13.26M | 2.02M | 15.23% |
| Q1 2022 Q2Q % growth | 540K -98.38% | 2.244M | -1.704M | -75.94% |
| Q4 2021 Q2Q % growth | 340K | 6.204M | -5.864M | -94.52% |
| Q3 2021 Q2Q % growth | 1.24M | 5.44M | -4.2M | -77.21% |
| Q2 2021 Q2Q % growth | 22.02M | 4.624M | 17.396M | 376.21% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.88% | -14.57% | -10.04% | -32.35% |
| Revenue | 1.93% | 10.08% | 0.92% | 7.41% |